🇺🇸 FDA
Pipeline program

CKD-581

133MM16010

Phase 1 small_molecule active

Quick answer

CKD-581 for Myeloma, Multiple is a Phase 1 program (small_molecule) at Hong Kong Baptist University with 1 ClinicalTrials.gov record(s).

Program details

Company
Hong Kong Baptist University
Indication
Myeloma, Multiple
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials